CombiMatrix (NASDAQ: [[ticker:CBMX]]), the Mukilteo, WA-based maker of genetic analysis and diagnostic tools, said today that two members of its board have resigned. Chairman Tom Akin, a large shareholder in the company, is stepping down from the board, along with Brooke Anderson, who is also resigning his full-time role as chief operating officer as the company is closing its Mukilteo facility and consolidating in Irvine, CA. Mark McGowan has been named the new chairman of the CombiMatrix board.
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
